Dr. Errol Norwitz, newly at Babson College’s Kerry Murphy Healey Center, argued that entrepreneurship must play a central role in remaking U.S. healthcare. In a Poets&Quants interview, Norwitz traced his shift from lab science to startup-led solutions and outlined Babson’s programs—global surgery slingshots, NIH-funded startup training—designed to translate R&D into patient impact. Norwitz framed the problem as structural: misaligned incentives and fragmented delivery systems that require business-model innovation more than incremental science. The Healey Center will focus on training clinician-entrepreneurs, venture incubation, and scaling care delivery innovations. University leaders and research offices should note the emphasis on translational entrepreneurship and partnerships with funders to accelerate commercialization of clinical innovations.